Lucia Del Mastro - Publications, H-index & Citations

Lucia Del Mastro

dimi

69H指数

835论文数

2.0W被引数

收录论文 134

发表时间

End‑of‑life care in advanced melanoma: a retrospective cohort study from an Italian comprehensive cancer center 晚期黑色素瘤的临终关怀：一项来自意大利综合癌症中心的回顾性队列研究

BMC Cancer

IF3.4

2026-02-21

OAAI

Michela De Mattia; Andrea Boutros; Virginia Delucchi; Eva Blondeaux; Matteo Lambertini; Agostina Lagodin D’Amato; Irene Giannubilo; Lucia Del Mastro; Paolo Pronzato; Claudia Bighin; Francesco Spagnolo; Enrica Teresa Tanda

Association Between Alcohol Consumption and Breast Cancer Incidence and Prognosis: A Systematic Review and Meta-Analysis 酒精摄入与乳腺癌发病率及预后的关系：一项系统评价和Meta分析

The Breast

IF0

2026-02-05

OAAI

Luca Arecco; Pedro Cacilhas; Camila Bobato Lara Gismondi; Marco Bruzzone; Gabriella Gentile; Riccardo Gerosa; Eva Blondeaux; Elisa Agostinetto; Chiara Dauccia; Soraia Lobo-Martins; Rafael Grochot; Kamal S. Saini; Hatem A. Azim; Marcio Debiasi; Alex De Caluwé; Laurence Buisseret; Lucia Del Mastro; Matteo Lambertini; Evandro de Azambuja

Validation of PREDICT tool v2.2 in patients with early-stage breast cancer enrolled in the GIM and MIG trials PREDICT工具v2.2在参与GIM和MIG试验的早期乳腺癌患者中的验证

ESMO Open

IF8.3

2026-01-06

OAAI

R. Borea; E. Blondeaux; L. Carmisciano; L. Arecco; M. Perachino; F. Poggio; T. Ruelle; F. Luelli; M. de Laurentiis; G. Arpino; F. Puglisi; A. Fabi; S. Gori; P. Fregatti; M. Lambertini; L. Boni; L. Del Mastro

OPERA-01: a phase III study of palazestrant for ER+, HER2-advanced breast cancer after CDK4/6 inhibitor therapy OPERA-01: CDK4/6抑制剂治疗后palazestrant治疗ER，HER2-advanced乳腺癌的III期研究

FUTURE ONCOLOGY

IF2.6

2026-01-01

PREAI

Pistilli, Barbara; Ezquerra, Meritxell Bellet; Del Mastro, Lucia; Sohn, Joohyuk; Schmid, Peter; Meisel, Jane; Chan, Arlene; Zheng, Lianqing; de Kermadec, Elisabeth; McArthur, Heather

Fertility and ovarian function preservation in young women with breast cancer: A joint analysis of the Joven & Fuerte and PREFER prospective studies 年轻乳腺癌女性患者的生育能力和卵巢功能保护：Joven & Fuerte和PREFER前瞻性研究的联合分析

The Breast

IF0

2025-10-01

OAAI

Fernanda Mesa-Chavez; Maria Grazia Razeti; Eva Blondeaux; Alejandra Platas; Virginia Delucchi; Alan Fonseca; Valeria Fontana; Marlid Cruz-Ramos; Paola Anserini; Manuel Rolando Gracía Garza; Edoardo Chiappe; Alejandro Mohar; Laura Orlando; Paula Cabrera-Galeana; Saverio Cinieri; Enrique Bargallo-Rocha; Lucia Del Mastro; Cynthia Villarreal-Garza; Matteo Lambertini

Comparative efficacy between real-world and randomized studies of palbociclib+endocrine therapy in HR-positive/HER2-negative metastatic breast cancer: systematic review and meta-analysis 真实世界研究与随机研究之间帕博西利布联合内分泌疗法在激素受体阳性/人表皮生长因子受体2阴性转移性乳腺癌中的比较疗效：系统评价与meta分析

JNCI CANCER SPECTRUM

IF4.1

2025-10-01

OAAI

Schettini, Francesco; Nucera, Sabrina; Di Grazia, Giuseppe; Giudici, Fabiola; Strina, Carla; Milani, Manuela; Tancredi, Richard; Conte, Benedetta; Criscitiello, Carmen; Giuliano, Mario; Lambertini, Matteo; Sanchez-Bayona, Rodrigo; Pascual, Tomas; Arpino, Grazia; Del Mastro, Lucia; Vigneri, Paolo; Cristofanilli, Massimo; Rugo, Hope S.; Gennari, Alessandra; Curigliano, Giuseppe; Generali, Daniele

Tumor-specific major histocompatibility-II expression predicts pathological complete response to atezolizumab combined to chemotherapy in triple-negative breast cancer 肿瘤特异性主要组织相容性-II表达预测三阴性乳腺癌中阿替利珠单抗联合化疗的病理完全缓解

npj Breast Cancer

IF7.6

2025-09-29

OAAI

Justin M. Balko; Luca Licata; Xiao Qian Wang; Matteo Dugo; Chiun-Sheng Huang; Daniel Egle; Begoña Bermejo; Claudio Zamagni; Marc Thill; Antonio Anton; Stefania Russo; Elena Sevillano; Eva Maria Ciruelos; Richard Greil; Vladimir Semiglazov; Marco Colleoni; Catherine M. Kelly; Gabriella Mariani; Lucia Del Mastro; Stefania Zambelli; Giulia Viale; Maurizio Callari; Giuseppe Viale; Lajos Pusztai; Luca Gianni; H. Raza Ali; Giampaolo Bianchini

Genomically matched therapy in advanced solid tumors: the randomized phase 2 ROME trial 基因组匹配疗法在晚期实体瘤中的应用：随机II期ROME试验

Nature Medicine

IF50

2025-09-29

OAAI

Paolo Marchetti; Giuseppe Curigliano; Mauro Biffoni; Sara Lonardi; Simone Scagnoli; Lorenzo Fornaro; Valentina Guarneri; Ugo De Giorgi; Paolo Antonio Ascierto; Giovanni Blandino; Giulia D’Amati; Massimo Aglietta; Chiara Cremolini; Pierfranco Conte; Edoardo Crimini; Maurizio Ceracchi; Simona Pisegna; Sofia Verkhovskaia; Roberto Bordonaro; Sergio Bracarda; Giovanni Butturini; Lucia Del Mastro; Andrea DeCensi; Agnese Fabbri; Elisabetta Fenocchio; Stefania Gori; Giulio Metro; Annamaria Pessino; Daniele Pozzessere; Fabio Puglisi; Stefano Tamberi; Alberto Zambelli; Donatella Marino; Ettore Capoluongo; Federico Cappuzzo; Bruna Cerbelli; Giuseppe Giannini; Umberto Malapelle; Federica Mazzuca; Marianna Nuti; Giancarlo Pruneri; Maurizio Simmaco; Lidia Strigari; Giuseppe Tonini; Nello Martini; Andrea Botticelli

Unlocking the Potential of Immune Checkpoint Inhibitors in HR+/HER2− Breast Cancer: A Systematic Review 解锁免疫检查点抑制剂在HR+/HER2−乳腺癌中的潜力：一项系统综述

Cancers 2025, Vol. 17, Page 2940

IF0

2025-09-23

OAAI

Giuseppe Di Grazia; Arianna Dri; Angela Grieco; Claudia Martinelli; Michela Palleschi; Federica Martorana; Giacomo Barchiesi; Grazia Arpino; Carmine De Angelis; Michelino De Laurentiis; Lucia Del Mastro; Fabio Puglisi; Paolo Vigneri; Mario Giuliano

Immunotherapy for resectable NSCLC: neoadjuvant/perioperative followed by surgery over surgery followed by adjuvant. Systematic review and meta-analysis with subgroup analyses 可切除非小细胞肺癌的免疫疗法：新辅助/围手术期治疗继之以手术优于手术继之以辅助治疗。系统评价与Meta分析及亚组分析

ESMO Open

IF8.3

2025-09-05

OAAI

G. Rossi; L. Barcellini; M. Tagliamento; E.T. Tanda; M.C. Garassino; E. Blondeaux; V. Delucchi; F. Spagnolo; L. Del Mastro; C. Genova

The use of bone-modifying agents in early breast cancer: AIOM Guidelines update and perspectives 骨改良剂在早期乳腺癌中的应用：AIOM 指南更新与展望

TUMORI JOURNAL

IF0

2025-09-01

PREAI

Zambelli, A.; Gerosa, R.; Cinquini, M.; Di Maio, M.; Miglietta, F.; Arecco, L.; Biganzoli, L.; Bernardi, D.; Cortesi, L.; Del Mastro, L.; Dieci, M. V.; Foglietta, J.; Fortunato, L.; Franco, P.; Mantellini, P.; Marchio, C.; Meduri, B.; Micallo, G.; Musolino, A.; Salvetti, A.; Santini, D.; Lanzetta, G.; Cosentini, D.; Bertoldo, F.; Cazzato, R. L.; Cellini, F.; Denaro, V.; Di Martino, A.; Fusco, V.; Greco, C.; Ibrahim, T.; Maccauro, G.; De Feo, G.; Severi, S.; Gori, S.

A-BRAVE trial: a Phase 3 randomized trial with anti-PD-L1 avelumab in high-risk triple-negative early breast cancer patients A-BRAVE试验：一项使用抗PD-L1药物avelumab治疗高风险三阴性早期乳腺癌患者的III期随机试验

Annals of Oncology

IF65.4

2025-08-28

OAAI

P.F. Conte; M.V. Dieci; G. Bisagni; P. Schmid; A. Zambelli; F. Piacentini; M. De Laurentiis; A.G. Favaretto; S. Tamberi; G.V. Bianchi; C. Zamagni; S. Cinieri; D.C. Corsi; L. Del Mastro; A. Ferro; A. Gennari; M. Mion; A. Musolino; L. Nicolé; P. Del Bianco; G.L. De Salvo; V. Guarneri

PREDICTIVE BRCA GENETIC TESTING IN ITALIAN PATIENTS WITH BREAST CANCER: A POSITION PAPER OF ITALIAN SCIENTIFIC SOCIETIES [Italian Association of Medical Oncology(AIOM); Italian Association of Radiotherapy and Clinical Oncology (AIRO); Italian National Association of Breast Surgeons (ANISC); Italian Society of Pathological Anatomy and Diagnostic Cytology (SIAPeC-IAP); Italian Society of Surgical Oncology (SICO); Italian Society of Human Genetic (SIGU); Italian Society of General Practice (SIMG); Italian Society of Medical and Interventional Radiology (SIRM)]意大利乳腺癌患者预测性BRCA基因检测：意大利科学学会立场文件[意大利医学肿瘤学会(AIOM)；意大利放射治疗与临床肿瘤学会 (AIRO)；意大利全国乳腺外科医师协会 (ANISC)；意大利病理解剖学与诊断细胞学学会 (SIAPeC-IAP)；意大利外科肿瘤学会 (SICO)；意大利人类遗传学会 (SIGU)；意大利全科医学学会 (SIMG)；意大利医学与介入放射学学会 (SIRM)]

Cancer Treatment Reviews

IF10.5

2025-06-15

PREAI

L. Cortesi; F. Miglietta; L. Arecco; D. Bernardi; L. Biganzoli; L. Del Mastro; MV. Dieci; J. Foglietta; L. Fortunato; P. Franco; E.Lucci Cordisco; P. Mantellini; C. Marchio’; B. Meduri; G. Micallo; A. Musolino; A. Salvetti; D. Turchetti; A. Zambelli; C. Angiolini; S. Cinieri; PF. Conte; G. Curigliano; M. Dessena; A. Fabi; MC. Leonardi; I. Meattini; S. Montemezzi; F. Puglisi; A. Sapino; M. Taffurelli; M. Cinquini; S. Gori

The evolving landscape of hormone receptor-positive/HER2-negative metastatic breast cancer (EVOLVE): An Italian Delphi consensus report 激素受体阳性/HER2阴性转移性乳腺癌的演变格局（EVOLVE）：一项意大利Delphi共识报告

critical reviews in oncology hematology

IF0

2025-06-06

OAAI

Federica Miglietta; Maria Grazia Razeti; Aldo Caltavituro; Arianna Dri; Carmine Valenza; Giampaolo Bianchini; Laura Biganzoli; Andrea Botticelli; Michele Caruso; Saverio Cinieri; Carmen Criscitiello; Carmine De Angelis; Michelino De Laurentis; Lucia Del Mastro; Sabino De Placido; Marzia Del Re; Maria Vittoria Dieci; Alessandra Fabi; Daniele Generali; Alessandra Gennari; Grazia Arpino

Letter response re: factors associated with first-to-second line attrition among patients with metastatic breast cancer in the real-world 函复：关于真实世界中转移性乳腺癌患者首线至二线治疗间流失相关因素的信函

ESMO Open

IF8.3

2025-06-01

PREAI

E. Blondeaux; M. Lambertini; F. Montemurro; L. Del Mastro

New insight in early detection and precision medicine in small cell lung cancer: liquid biopsy as innovative clinical tool 小细胞肺癌早期检测与精准医学的新见解：液体活检作为创新临床工具

CRITICAL REVIEWS IN CLINICAL LABORATORY SCIENCES

IF5.5

2025-05-26

OAAI

Sara Santamaria; Barbara Cardinali; Matteo Rovere; Silvia Marconi; Simone Nardin; Gianluca Sacco; Lucrezia Barcellini; Lucia Del Mastro; Carlo Genova; Simona Coco

Response to Venkataraman and Mokbel 对Venkataraman和Mokbel的回应

JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE

IF7.2

2025-05-08

PREAI

Arecco, Luca; Blondeaux, Eva; Agostinetto, Elisa; De Azambuja, Evandro; Lambertini, Matteo; Del Mastro, Lucia

Extended adjuvant endocrine therapy in early breast cancer: finding the individual balance 早期乳腺癌的延长辅助内分泌治疗：寻找个体化平衡

ESMO OPEN

IF8.3

2025-05-01

PREAI

Lobo-Martins, S.; Arecco, L.; Cabral, T. P.; Agostinetto, E.; Dauccia, C.; Franzoi, M. A.; del Mastro, L.; Lambertini, M.; Piccart, M.; de Azambuja, E.

Different activity and toxicity of immunotherapy in monozygotic twins diagnosed with early triple-negative breast cancer: a case report 同卵双胞胎早期三阴性乳腺癌患者免疫疗法活性与毒性的差异：病例报告

THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY

IF4.2

2025-02-18

OAAI

Marta Perachino; Lucia Del Mastro; Giulia Buzzatti; Lucia Trevisan; Maria Grazia Razeti; Andrea Bellodi; Stefano Spinaci; Davide Soldato; Matteo Lambertini; Francesca Poggio

Factors associated with first-to-second-line attrition among patients with metastatic breast cancer in the real world

ESMO OPEN

IF8.3

2025-02-01

OAAI

Blondeaux, E.; Boni, L.; Chila, G.; Dri, A.; Caputo, R.; Poggio, F.; Fabi, A.; Arpino, G.; Pravisano, F.; Geuna, E.; Delucchi, V.; Ruelle, T.; Giannubilo, I.; De Laurentiis, M.; Puglisi, F.; Bighin, C.; Lambertini, M.; Montemurro, F.; Del Mastro, L.

研究方向